Details

Difference in methylation and expression of brain-derived neurotrophic factor in Alzheimer’s disease and mild cognitive impairment
ID Kouter, Katarina (Author), ID Videtič Paska, Alja (Author), et al.

.pdfPDF - Presentation file, Download (951,72 KB)
MD5: ADDD54875EDC1BB916A509CB7E9372FE
URLURL - Source URL, Visit https://www.mdpi.com/2227-9059/11/2/235 This link opens in a new window

Abstract
Due to the increasing number of progressive dementias in the population, numerous studies are being conducted that seek to determine risk factors, biomarkers and pathological mechanisms that could help to differentiate between normal symptoms of aging, mild cognitive impairment (MCI) and dementia. The aim of this study was to investigate the possible association of levels of BDNF and COMT gene expression and methylation in peripheral blood cells with the development of Alzheimer’s disease (AD). Our results revealed higher expression levels of BDNF (p < 0.001) in MCI subjects compared to individuals diagnosed with AD. However, no difference in COMT gene expression (p = 0.366) was detected. DNA methylation of the CpG islands and other sequences with potential effects on gene expression regulation revealed just one region (BDNF_9) in the BDNF gene (p = 0.078) with marginally lower levels of methylation in the AD compared to MCI subjects. Here, we show that the level of BDNF expression in the periphery is decreased in subjects with AD compared to individuals with MCI. The combined results from the gene expression analysis and DNA methylation analysis point to the potential of BDNF as a marker that could help distinguish between MCI and AD patients.

Language:English
Keywords:epigenetics, DNA methylation, Alzheimer’s dementia, gene expression, dementia, brain-derived neurotrophic factor, BDNF, catechol-o-methyltransferase, COMT, cognitive impairment
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:17 str.
Numbering:Vol. 11, iss. 2, art. 235
PID:20.500.12556/RUL-165219 This link opens in a new window
UDC:616.8
ISSN on article:2227-9059
DOI:10.3390/biomedicines11020235 This link opens in a new window
COBISS.SI-ID:138123267 This link opens in a new window
Publication date in RUL:27.11.2024
Views:465
Downloads:144
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomedicines
Shortened title:Biomedicines
Publisher:MDPI
ISSN:2227-9059
COBISS.SI-ID:523006745 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:epigenetika, metilacija DNA, Alzheimerjeva demenca, izražanje genov, demenca, nevrotrofični dejavnik možganskega izvora, MDMI, katehol-O-metil transferaza, COMT, kognitivna motnja

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARRS - Slovenian Research Agency
Project number:J3-9293
Name:Zgodnje odkrivanje Alzheimerjeve bolezni z določanjem metilacije kandidatnih genov v prosti cirkulirajoči DNA

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back